Navigation Links
SCOLR Pharma, Inc. Launches Cutting Edge Nutritional Products at Major Retailers in 2012
Date:2/16/2012

BOTHELL, Wash., Feb. 16, 2012 /PRNewswire/ -- SCOLR Pharma, Inc. (OTCQB: SCLR) announced today that it has launched several new extended-release nutritional/vitamin products based on the Company's patented oral drug delivery platform, Controlled Delivery Technology (CDT®). Eleven class-leading products are now being sold under various private label brands across the country at the nation's top retail chains. 

Each product has been designed to deliver the full nutritional or vitamin dosage over a period of time from 12 to 24 hours.  The products are available on the vitamin/nutritional supplement aisles and are easily identifiable by their 12 or 24 Hour package logo and/or Extended Release or Controlled Release nomenclature.

The Company's flagship extended release formulations are Niacin 500mg 12HR Controlled-Release, Vitamin C 1000 mg 12HR, CoQ-10 100 mg 24HR, Glucosamine Chondroitin MSM Advanced 12HR Combo, and three 24HR calcium formulations; Calcium 1200 +D with calcium citrate, Calcium + Vitamin D Plus Minerals, and Calcium + Vitamins D & K.

The Company has plans later this year to launch several new nutritional/vitamin products under its house brand SCOLR® and for additional private label products with new and existing retailers.

Stephen J. Turner, SCOLR Pharma's President and CEO, said, "This is an exciting and landmark step for SCOLR.  The acceptance by so many retailers of our nutritional products indicates there is a strong consumer demand for extended release nutritional products and vitamins. We are very enthused about the business opportunity this represents for SCOLR and our patented technologies. "

About SCOLR Pharma:
Based in Bothell, Washington, SCOLR Pharma, Inc. is a specialty pharmaceutical company focused on applying its formulation expertise and patented CDT platforms to develop novel prescription pharmaceutical, over-the-counter (OTC), and nutritional products. Its CDT drug delivery platforms are based on multiple issued and pending patents and other intellectual property for the programmed release or enhanced performance of active pharmaceutical ingredients and nutritional products. For more information on SCOLR Pharma, please call 425-368-1050 or visit http://www.scolr.com/.

Forward looking statements: 
Any statements made in this press release that relate to future plans, events or performance are forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  These forward looking statements include statements regarding anticipated developments in the Company's nutritional business.  Factors that could cause these forward-looking statements to differ from actual results include delays in manufacturing, labeling or shipment of products, order revisions, or variations in retailer's marketing plans, and other risks and uncertainties discussed in the company's periodic reports on Form 10-K and 10-Q and other filings with the Securities and Exchange Commission.  SCOLR Pharma, Inc. undertakes no obligation to update or revise any forward-looking statements.

Contacts:
Investor Relations:                                             
SCOLR Pharma, Inc.                                            
425.368.1050


'/>"/>
SOURCE SCOLR Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SCOLR Pharmas Partner to Commence Bioequivalence Study of Ondansetron
2. SCOLR Pharma, Inc. Announces Initial Shipments of its Nutritional Products
3. SCOLR Pharma, Inc. Announces Second Quarter 2011 Financial Results
4. SCOLR Pharma, Inc. First Quarter 2011 Financial Results
5. SCOLR Pharma, Inc. to Present at Taglich Brothers 8th Annual Small Cap Equity Conference
6. SCOLR Pharma, Inc. Reports 2010 Financial Results, Provides Updates on Advances in Nutritionals, OTC Drugs
7. SCOLR Pharma, Inc. Receives Deficiency Letter from FDA on Pseudoephedrine Application
8. SCOLR Pharma, Inc. Retains Nicholas Hall & Company
9. SCOLR Pharma, Inc. Common Stock to Begin Trading on OTC Bulletin Board and OTCQB Stock Market on January 13, 2011
10. SCOLR Pharma, Inc. Announces Intention to Voluntarily Delist From NYSE AMEX Exchange
11. SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... Sept. 19, 2017   ZirMed Inc ., a recognized ... announced that it has been ranked #1 by its users ... Rankings 2017 User Survey. ZirMed was recognized as the ... hospitals and medical centers over 200 beds and holds one ... technology user survey history. ...
(Date:9/12/2017)... 12, 2017  Consumer reviews on the independent review site ... number one company for hearing aids, ranking it higher than ... ... by Consumers For Hearing Aids ... is an online store that provides high performance, state-of-the-art, German-engineered hearing ...
(Date:9/7/2017)... , Sept. 7, 2017  Eli Lilly and ... actions to streamline operations to more efficiently focus ... its cost structure. Global workforce reductions, including those ... expected to impact approximately 3,500 positions. ... expects annualized savings of approximately $500 million that ...
Breaking Medicine Technology:
(Date:9/21/2017)... , ... September 21, 2017 , ... 38-Year-Old Plastic Surgeon ... Center in Naples, Florida is pleased to announce that Plastic Surgeon Kiranjeet Gill has ... 40 Under 40 is an annual award that was started in 2003 to ...
(Date:9/21/2017)... ... September 21, 2017 , ... Hair restoration ... member survey conducted by the International Society of Hair Restoration Surgery ... 2016 rose 60 percent, with 635,189 procedures performed in 2016. , "Like ...
(Date:9/21/2017)... ... September 21, 2017 , ... The New England Center for ... today the election of Yie-Hsin Hung to the Board of Directors. , “The ... of Directors. Ms. Hung is an invaluable addition to our team,” said Vincent Strully, ...
(Date:9/21/2017)... ... September 21, 2017 , ... Sagora ... acquisition of Isle at Kingwood Assisted Living and Memory Care located at 24025 ... community with 55 assisted living apartments, 43 memory care apartments and 23 extended ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... Coating System for clients that rely on safety and cleanliness. This unique flooring ... , Silver has been used for centuries for its antimicrobial properties. Unlike antibiotics, ...
Breaking Medicine News(10 mins):